CIK 0001583771
- Non-accelerated filer
- Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462783806
- Phone
- +1 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- Open-market buys, last 90 days
- $10,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-18 | SYNERGY PHARMACEUTICALS, INC. 10% owner | Other disposition | −9,000,000 | 0 | ||
| 2014-01-24 | BRANCACCIO JOHN P Director | Grant or award · Stock Options | +30,000 | 60,000 | ||
| 2014-01-24 | Denoyer Bernard Director | Grant or award · Stock Options | +10,000 | 20,000 | ||
| 2014-01-24 | Block Timothy M. Director | Grant or award · Stock Options | +10,000 | 40,000 | ||
| 2014-01-24 | JACOB GARY S CEO and President | Grant or award · Stock Options | +200,000 | 230,000 | ||
| 2014-01-24 | McGuigan Christopher Director | Grant or award · Stock Options | +250,000 | 280,000 | ||
| 2013-11-26 | Denoyer Bernard CFO and Secretary | Grant or award · Stock Options | +10,000 | 10,000 |
Page 8 of 8 · 147 trades